Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.
Saved in:
| Title: | Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study. |
|---|---|
| Authors: | Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Koo JY; UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USA., Jaworski J; Centrum Medyczne Reuma Park, Warsaw, Poland., Trefler J; Reuma Centrum, Warsaw, Poland., Daniluk S; ClinicMed Daniluk, Nowak Sp.K, Białystok, Poland., Dudek A; Centrum Medyczne AMED, Warsaw, Poland., Baran W; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland., Owczarek W; Royalderm/Department of Dermatology, Military Institute of Medicine-National Research Institute, Warsaw, Poland., Kolinek J; Medycyna Kliniczna, Warsaw, Poland., Brzewski P; Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Krakow, Poland., Sikora M; National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Krogulec M; Rheumatology Clinic NZOZ Lecznica MAK-MED, Nadarzyn, Poland., Kim S; Celltrion, Inc., Incheon, Republic of Korea., Bae Y; Celltrion, Inc., Incheon, Republic of Korea., Jeon D; Celltrion, Inc., Incheon, Republic of Korea., Choi E; Celltrion, Inc., Incheon, Republic of Korea., Cha J; Celltrion, Inc., Incheon, Republic of Korea., Lee H; Celltrion, Inc., Incheon, Republic of Korea., Choi S; Celltrion, Inc., Incheon, Republic of Korea., Pariser DM; Eastern Virginia Medical School and Virginia Clinical Research, Inc., 6160 Kempsville Circle, Suite 200A, Norfolk, VA, 23502, USA. dpariser@pariserderm.com. |
| Source: | Advances in therapy [Adv Ther] 2025 Sep; Vol. 42 (9), pp. 4720-4723. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40650708 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lebwohl+MG%22">Lebwohl MG</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Koo+JY%22">Koo JY</searchLink>; UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jaworski+J%22">Jaworski J</searchLink>; Centrum Medyczne Reuma Park, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Trefler+J%22">Trefler J</searchLink>; Reuma Centrum, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Daniluk+S%22">Daniluk S</searchLink>; ClinicMed Daniluk, Nowak Sp.K, Białystok, Poland.<br /><searchLink fieldCode="AU" term="%22Dudek+A%22">Dudek A</searchLink>; Centrum Medyczne AMED, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Baran+W%22">Baran W</searchLink>; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Owczarek+W%22">Owczarek W</searchLink>; Royalderm/Department of Dermatology, Military Institute of Medicine-National Research Institute, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Kolinek+J%22">Kolinek J</searchLink>; Medycyna Kliniczna, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Brzewski+P%22">Brzewski P</searchLink>; Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Sikora+M%22">Sikora M</searchLink>; National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Krogulec+M%22">Krogulec M</searchLink>; Rheumatology Clinic NZOZ Lecznica MAK-MED, Nadarzyn, Poland.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+Y%22">Bae Y</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+D%22">Jeon D</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+E%22">Choi E</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cha+J%22">Cha J</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+S%22">Choi S</searchLink>; Celltrion, Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Pariser+DM%22">Pariser DM</searchLink>; Eastern Virginia Medical School and Virginia Clinical Research, Inc., 6160 Kempsville Circle, Suite 200A, Norfolk, VA, 23502, USA. dpariser@pariserderm.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Sep; Vol. 42 (9), pp. 4720-4723. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40650708 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-025-03235-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4720 Titles: – TitleFull: Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lebwohl MG – PersonEntity: Name: NameFull: Koo JY – PersonEntity: Name: NameFull: Jaworski J – PersonEntity: Name: NameFull: Trefler J – PersonEntity: Name: NameFull: Daniluk S – PersonEntity: Name: NameFull: Dudek A – PersonEntity: Name: NameFull: Baran W – PersonEntity: Name: NameFull: Owczarek W – PersonEntity: Name: NameFull: Kolinek J – PersonEntity: Name: NameFull: Brzewski P – PersonEntity: Name: NameFull: Sikora M – PersonEntity: Name: NameFull: Krogulec M – PersonEntity: Name: NameFull: Kim S – PersonEntity: Name: NameFull: Bae Y – PersonEntity: Name: NameFull: Jeon D – PersonEntity: Name: NameFull: Choi E – PersonEntity: Name: NameFull: Cha J – PersonEntity: Name: NameFull: Lee H – PersonEntity: Name: NameFull: Choi S – PersonEntity: Name: NameFull: Pariser DM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 42 – Type: issue Value: 9 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
